Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
51.9M
Number of holders
61
Total 13F shares, excl. options
30.6M
Shares change
+1.88M
Total reported value, excl. options
$170M
Value change
+$10.4M
Put/Call ratio
0
Number of buys
27
Number of sells
-19
Price
$5.57

Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q4 2024

73 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q4 2024.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.6M shares of 51.9M outstanding shares and own 58.98% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.9M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.69M shares), Nantahala Capital Management, LLC (3.53M shares), MILLENNIUM MANAGEMENT LLC (2.12M shares), Western Standard LLC (2.08M shares), VANGUARD GROUP INC (1.97M shares), Vivo Capital, LLC (1.84M shares), Rosalind Advisors, Inc. (1.81M shares), Laurion Capital Management LP (1.31M shares), and 683 Capital Management, LLC (792K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.